abstract |
The present invention relates to a VEGF polypeptide that binds to beta-amyloid. The present invention also relates to a compound that sequesters beta-amyloid. And conversely, the invention relates to a compound that sequesters VEGF. Thus, the present invention also relates to a method of screening for a compound that inhibits the binding of VEGF to beta-amyloid, and thus relates to diagnosis and treatment of Alzheimer's Disease. |